All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
NRX PHARMACEUTICALS, INC. Last Reported: 2/29/2024 Stock Symbol: NRXP

Business Address

1201 ORANGE STREET
SUITE 600
WILMINGTON , DE US 19801

Mailing Address

1201 ORANGE STREET
SUITE 600
WILMINGTON , DE US 19801
Phone Number: 484-254-6134 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Cash and Cash Equivalents $8,902,000.00 $14,969,000.00 $20,054,000.00 $18,249,000.00 $24,548,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,187,000.00 $4,819,000.00 $5,741,000.00 $6,552,000.00 $7,866,000.00 $5,109,000.00 $6,350,889.00 $5,147,650.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $13,089,000.00 $19,788,000.00 $25,795,000.00 $24,801,000.00 $32,414,000.00 $32,714,000.00 $45,234,458.00 $18,533,982.00 $82,458.00 $97,104.00 $36,803.00 $80,774.00 $69,489.00 $208,030.00 $41,277.00 $50,716.00 $30,193.00 $123,816.00 $216,046.00 $334,969.00 $536,376.00
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $21,000.00 $21,000.00 $21,000.00 $23,000.00 $19,000.00 $15,000.00 $15,921.00 $12,730.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $13,110,000.00 $19,809,000.00 $25,816,000.00 $24,824,000.00 $32,433,000.00 $32,729,000.00 $45,250,379.00 $18,546,712.00 $6,050,405.00 $6,031,775.00 $6,277,048.00 $6,272,781.00 $32,074,694.00 $41,685,076.00 $50,102,727.00 $71,707,751.00 $70,796,159.00 $69,885,185.00 $69,698,976.00 $69,553,248.00 $69,565,819.00
Accounts Payable $3,631,000.00 $2,205,000.00 $2,076,000.00 $2,168,000.00 $3,078,000.00 $3,687,000.00 $5,559,412.00 $6,268,319.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities $4,728,000.00 $5,783,000.00 $4,855,000.00 $5,067,000.00 $3,326,000.00 $2,375,000.00 $1,995,961.00 $1,506,337.00 -- -- -- -- -- -- -- -- -- -- -- -- $7,500.00
Total Current Liabilities $19,327,000.00 $22,617,000.00 $18,407,000.00 $8,042,000.00 $7,081,000.00 $11,923,000.00 $36,282,975.00 $35,984,055.00 $3,281,546.00 $2,830,564.00 $2,650,805.00 $2,497,037.00 $2,574,205.00 $2,433,757.00 $2,108,016.00 $1,981,037.00 $1,257,410.00 -- -- -- $93,171.00
Long Term Debt $10,069,000.00 $12,692,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-22,000.00 $-22,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-248,815,000.00 $-242,753,000.00 $-222,997,000.00 $-212,756,000.00 $-203,673,000.00 $-183,243,000.00 $-152,449,666.00 $-131,676,567.00 $-64,917.00 $367,435.00 $493,214.00 $642,715.00 $369,495.00 $384,249.00 $325,054.00 $149,033.00 $-38,932.00 $-68,071.00 $-96,154.00 $-89,552.00 $-105,033.00
Total Stockholders' Equity $-6,217,000.00 $-2,808,000.00 $7,409,000.00 $16,782,000.00 $25,352,000.00 $20,806,000.00 $8,967,404.00 $-17,437,343.00 $2,768,859.00 $3,201,211.00 $3,626,243.00 $3,775,744.00 $5,000,001.00 $5,000,006.00 $5,000,008.00 $5,000,005.00 $5,000,006.00 $5,000,009.00 $5,000,009.00 $5,000,005.00 $5,000,001.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $13,110,000.00 $19,809,000.00 $25,816,000.00 $24,824,000.00 $32,433,000.00 $32,729,000.00 $45,250,379.00 $18,546,712.00 $6,050,405.00 $6,031,775.00 $6,277,048.00 $6,272,781.00 $32,074,694.00 $41,685,076.00 $50,102,727.00 $71,707,751.00 $70,796,159.00 $69,885,185.00 $69,698,976.00 $69,553,248.00 $69,565,819.00

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $3,314,000.00 $7,523,000.00 $17,027,000.00 $4,129,000.00 $2,958,000.00 $20,257,000.00 $13,843,895.00 $7,567,984.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $5,808,000.00 $8,188,000.00 $44,335,000.00 $34,447,000.00 $9,600,000.00 $115,796,000.00 $20,099,151.00 $42,721,317.00 $907,406.00 $469,587.00 $300,559.00 $119,300.00 $713,187.00 $522,228.00 $338,923.00 $163,181.00 $1,006,503.00 $1,187.00 $271,810.00 $192,374.00 $134,476.00
Loss from Operations $-23,431,000.00 $-8,188,000.00 $-44,335,000.00 $-34,447,000.00 $-9,600,000.00 $-115,796,000.00 $-20,099,151.00 $-42,721,317.00 $-907,406.00 $-469,587.00 $-181,259.00 $-119,300.00 $-713,187.00 $-522,228.00 $-338,923.00 $-163,181.00 $-1,006,503.00 $-684,427.00 $-464,184.00 $-192,374.00 $-134,476.00
Loss Before Income Taxes -- -- $-39,754,000.00 -- -- $-93,063,000.00 $-62,269,946.00 $-41,496,847.00 $-416,571.00 $21,137.00 $189,606.00 $345,848.00 $492,633.00 $511,309.00 $436,378.00 $219,681.00 $82,412.00 $63,073.00 $21,942.00 $19,596.00 $-105,033.00
Earnings Per Share Basic $-0.07 $-0.28 $-0.60 $-0.14 $-0.32 $-1.98 $-0.40 $-1.07 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 74,114,180 70,260,622 65,766,786 65,532,409 64,348,966 46,917,701 51,739,452 38,709,614 -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.35 $-0.12 $-0.60 $-0.45 $-0.11 $-1.98 $-0.40 $-1.07 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 74,114,180 70,260,622 65,766,786 66,449,593 65,732,343 46,917,701 51,050,182 38,709,614 -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000
Common Stock Shares Outstanding 83,919,554 80,388,330 66,442,989 67,641,314 66,641,314 58,510,550 -- 48,603,585 2,688,242 2,688,242 2,716,028 2,716,028 2,305,335 2,810,261 2,801,350 2,794,297 2,725,039 2,638,062 2,622,584 2,605,782 2,590,985
Common Stock Value $84,000.00 $80,000.00 $67,000.00 $68,000.00 $67,000.00 $59,000.00 $54,810.00 $48,604.00 $2,688.00 $2,688.00 $2,716.00 $2,716.00 $2,844.00 $2,810.00 $2,801.00 $2,794.00 $2,725.00 $2,638.00 $2,623.00 $2,606.00 $2,591.00
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Share Price -- -- -- -- -- $4.78 $9.27 $11.62 -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com